Vitamin K2 and Heart Health: What the VITAK-CAC Trial Tells Us

In this episode of Supplement Source, CRN’s Jeff Ventura speaks with Dr. Leon Schurgers, professor of biochemistry of vascular calcification at Maastricht University, about new research examining vitamin K2 and cardiovascular health. Dr. Schurgers takes us inside the VITAK-CAC trial, a placebo-controlled, double-blind study examining whether vitamin K2 as MK-7 can influence the progression of coronary artery calcification. He explains why calcification matters, how vitamin K-dependent p...